

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.65308379 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.65308379 |
| 3 | epoxygenase P450 pathway (GO:0019373) | 7.57592934 |
| 4 | omega-hydroxylase P450 pathway (GO:0097267) | 7.39226412 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.33344415 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 7.33344415 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 6.98413452 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 6.39197363 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 6.39197363 |
| 10 | tryptophan catabolic process (GO:0006569) | 6.39197363 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.22372142 |
| 12 | kynurenine metabolic process (GO:0070189) | 6.14492544 |
| 13 | tryptophan metabolic process (GO:0006568) | 6.00316187 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.98636544 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.94636358 |
| 16 | drug metabolic process (GO:0017144) | 5.94516500 |
| 17 | oxidative demethylation (GO:0070989) | 5.79061026 |
| 18 | urea cycle (GO:0000050) | 5.63438347 |
| 19 | urea metabolic process (GO:0019627) | 5.63438347 |
| 20 | cysteine metabolic process (GO:0006534) | 5.58498085 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 5.55202910 |
| 22 | negative regulation of fibrinolysis (GO:0051918) | 5.50661887 |
| 23 | high-density lipoprotein particle remodeling (GO:0034375) | 5.47072818 |
| 24 | alpha-linolenic acid metabolic process (GO:0036109) | 5.43681192 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.39287190 |
| 26 | regulation of fibrinolysis (GO:0051917) | 5.34351793 |
| 27 | protein carboxylation (GO:0018214) | 5.29112115 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.29112115 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.19356307 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 5.18939482 |
| 31 | phenylpropanoid metabolic process (GO:0009698) | 5.18531610 |
| 32 | complement activation, alternative pathway (GO:0006957) | 5.14657903 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 5.12734446 |
| 34 | regulation of plasminogen activation (GO:0010755) | 5.11823874 |
| 35 | bile acid metabolic process (GO:0008206) | 5.08390858 |
| 36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.00468457 |
| 37 | homocysteine metabolic process (GO:0050667) | 4.96582246 |
| 38 | ethanol metabolic process (GO:0006067) | 4.91395362 |
| 39 | regulation of complement activation (GO:0030449) | 4.83787568 |
| 40 | tyrosine metabolic process (GO:0006570) | 4.83589573 |
| 41 | regulation of cholesterol esterification (GO:0010872) | 4.81075795 |
| 42 | lysine metabolic process (GO:0006553) | 4.81003750 |
| 43 | lysine catabolic process (GO:0006554) | 4.81003750 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 4.80109250 |
| 45 | alpha-amino acid catabolic process (GO:1901606) | 4.78490626 |
| 46 | reverse cholesterol transport (GO:0043691) | 4.77609013 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.71493884 |
| 48 | negative regulation of hemostasis (GO:1900047) | 4.71493884 |
| 49 | polyketide metabolic process (GO:0030638) | 4.71087107 |
| 50 | doxorubicin metabolic process (GO:0044598) | 4.71087107 |
| 51 | daunorubicin metabolic process (GO:0044597) | 4.71087107 |
| 52 | protein-lipid complex remodeling (GO:0034368) | 4.68529743 |
| 53 | macromolecular complex remodeling (GO:0034367) | 4.68529743 |
| 54 | plasma lipoprotein particle remodeling (GO:0034369) | 4.68529743 |
| 55 | glycine metabolic process (GO:0006544) | 4.66105929 |
| 56 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.61008293 |
| 57 | * amino-acid betaine metabolic process (GO:0006577) | 4.58707760 |
| 58 | acylglycerol homeostasis (GO:0055090) | 4.57749156 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.57749156 |
| 60 | cellular ketone body metabolic process (GO:0046950) | 4.53464870 |
| 61 | response to mercury ion (GO:0046689) | 4.52647702 |
| 62 | indolalkylamine metabolic process (GO:0006586) | 4.51878984 |
| 63 | negative regulation of sterol transport (GO:0032372) | 4.49301471 |
| 64 | negative regulation of cholesterol transport (GO:0032375) | 4.49301471 |
| 65 | phospholipid efflux (GO:0033700) | 4.48216776 |
| 66 | amine catabolic process (GO:0009310) | 4.47955063 |
| 67 | cellular biogenic amine catabolic process (GO:0042402) | 4.47955063 |
| 68 | serine family amino acid metabolic process (GO:0009069) | 4.47917047 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.41386869 |
| 70 | alkaloid metabolic process (GO:0009820) | 4.37101077 |
| 71 | coenzyme catabolic process (GO:0009109) | 4.34172437 |
| 72 | negative regulation of coagulation (GO:0050819) | 4.33632935 |
| 73 | bile acid and bile salt transport (GO:0015721) | 4.32802151 |
| 74 | imidazole-containing compound metabolic process (GO:0052803) | 4.31494642 |
| 75 | glutamate metabolic process (GO:0006536) | 4.29661677 |
| 76 | intestinal cholesterol absorption (GO:0030299) | 4.26564978 |
| 77 | plasma lipoprotein particle clearance (GO:0034381) | 4.26064328 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 4.25961240 |
| 79 | cellular glucuronidation (GO:0052695) | 4.25476590 |
| 80 | negative regulation of wound healing (GO:0061045) | 4.24528420 |
| 81 | negative regulation of protein activation cascade (GO:2000258) | 4.20282241 |
| 82 | benzene-containing compound metabolic process (GO:0042537) | 4.19970138 |
| 83 | drug catabolic process (GO:0042737) | 4.18882789 |
| 84 | acute-phase response (GO:0006953) | 4.14724064 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 4.14169341 |
| 86 | flavonoid metabolic process (GO:0009812) | 4.13385050 |
| 87 | cholesterol efflux (GO:0033344) | 4.13247918 |
| 88 | arginine metabolic process (GO:0006525) | 4.06322407 |
| 89 | regulation of humoral immune response (GO:0002920) | 4.06018602 |
| 90 | positive regulation of blood coagulation (GO:0030194) | 4.05098497 |
| 91 | positive regulation of hemostasis (GO:1900048) | 4.05098497 |
| 92 | aldehyde catabolic process (GO:0046185) | 4.01287411 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.98243915 |
| 94 | ethanol oxidation (GO:0006069) | 3.98202531 |
| 95 | primary alcohol catabolic process (GO:0034310) | 3.95598132 |
| 96 | fibrinolysis (GO:0042730) | 3.94740448 |
| 97 | plasma lipoprotein particle assembly (GO:0034377) | 3.94715280 |
| 98 | ketone body metabolic process (GO:1902224) | 3.92000251 |
| 99 | low-density lipoprotein particle remodeling (GO:0034374) | 3.90394006 |
| 100 | hormone catabolic process (GO:0042447) | 3.87249446 |
| 101 | carboxylic acid catabolic process (GO:0046395) | 3.85977726 |
| 102 | organic acid catabolic process (GO:0016054) | 3.85977726 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.83715635 |
| 104 | short-chain fatty acid metabolic process (GO:0046459) | 3.82585267 |
| 105 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.82062694 |
| 106 | urate metabolic process (GO:0046415) | 3.81882222 |
| 107 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.81620761 |
| 108 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.81620761 |
| 109 | glucuronate metabolic process (GO:0019585) | 3.81333340 |
| 110 | uronic acid metabolic process (GO:0006063) | 3.81333340 |
| 111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.79872547 |
| 112 | positive regulation of coagulation (GO:0050820) | 3.79593019 |
| 113 | * S-adenosylmethionine metabolic process (GO:0046500) | 3.75017884 |
| 114 | heme transport (GO:0015886) | 3.72316528 |
| 115 | cofactor catabolic process (GO:0051187) | 3.71983837 |
| 116 | drug transmembrane transport (GO:0006855) | 3.71944411 |
| 117 | acetyl-CoA metabolic process (GO:0006084) | 3.71520793 |
| 118 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.71212644 |
| 119 | cholesterol homeostasis (GO:0042632) | 3.70006080 |
| 120 | NAD biosynthetic process (GO:0009435) | 3.69410093 |
| 121 | exogenous drug catabolic process (GO:0042738) | 3.69320884 |
| 122 | negative regulation of lipase activity (GO:0060192) | 3.68324635 |
| 123 | phospholipid homeostasis (GO:0055091) | 3.65729536 |
| 124 | complement activation, classical pathway (GO:0006958) | 3.65414677 |
| 125 | sterol homeostasis (GO:0055092) | 3.64327594 |
| 126 | pyridine nucleotide biosynthetic process (GO:0019363) | 3.64169222 |
| 127 | nicotinamide nucleotide biosynthetic process (GO:0019359) | 3.64169222 |
| 128 | positive regulation of lipid catabolic process (GO:0050996) | 3.62622036 |
| 129 | protein activation cascade (GO:0072376) | 3.62169601 |
| 130 | xenobiotic metabolic process (GO:0006805) | 3.61791007 |
| 131 | complement activation (GO:0006956) | 3.61101680 |
| 132 | cytolysis (GO:0019835) | 3.53706497 |
| 133 | sodium-independent organic anion transport (GO:0043252) | 3.51774955 |
| 134 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.51129426 |
| 135 | negative regulation of complement activation (GO:0045916) | 3.45042145 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.45915031 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.21239813 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 7.14313874 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.47149358 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.30006226 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.20707702 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.72117209 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.18210009 |
| 9 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.89766245 |
| 10 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.07772608 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04715529 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.9464585 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.95264309 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.78699296 |
| 15 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.68108201 |
| 16 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.54489901 |
| 17 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.52532881 |
| 18 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43771880 |
| 19 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.31607131 |
| 20 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.31137161 |
| 21 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.30068527 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.29227481 |
| 23 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.24940070 |
| 24 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23794855 |
| 25 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.07297707 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06192122 |
| 27 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.05639336 |
| 28 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.05096347 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.02552165 |
| 30 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.01426226 |
| 31 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.00722248 |
| 32 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.96932808 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.96595052 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95780578 |
| 35 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.95126834 |
| 36 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.94729597 |
| 37 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.94031178 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93729464 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.93205751 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.92924112 |
| 41 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92812002 |
| 42 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.89358406 |
| 43 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.89354134 |
| 44 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.88400005 |
| 45 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87936985 |
| 46 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.87415615 |
| 47 | CJUN_26792858_Chip-Seq_BT549_Human | 0.87229777 |
| 48 | NFYA_21822215_ChIP-Seq_K562_Human | 0.85094111 |
| 49 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.84474514 |
| 50 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.84314096 |
| 51 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83747088 |
| 52 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.83381962 |
| 53 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.82574566 |
| 54 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.82272351 |
| 55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81771993 |
| 56 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81731708 |
| 57 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80942187 |
| 58 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.79368405 |
| 59 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.78581164 |
| 60 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.77894954 |
| 61 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.77612133 |
| 62 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.76737393 |
| 63 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.76288911 |
| 64 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.76199084 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.76199084 |
| 66 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.76175400 |
| 67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.74401063 |
| 68 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.71944480 |
| 69 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.70750621 |
| 70 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.69860127 |
| 71 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.69564106 |
| 72 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.69275800 |
| 73 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.69189261 |
| 74 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.68944880 |
| 75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.68349651 |
| 76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.67108988 |
| 77 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.67097471 |
| 78 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.66808444 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.66310358 |
| 80 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.66087625 |
| 81 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.66059035 |
| 82 | NFYB_21822215_ChIP-Seq_K562_Human | 0.65875274 |
| 83 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.65201187 |
| 84 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.65057437 |
| 85 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65010522 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.64977495 |
| 87 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.64785119 |
| 88 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64753079 |
| 89 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.64631570 |
| 90 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.64133328 |
| 91 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.63972549 |
| 92 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.63951123 |
| 93 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.60821112 |
| 94 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.59286495 |
| 95 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.59258336 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.57812845 |
| 97 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.55201169 |
| 98 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.53909905 |
| 99 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.53907931 |
| 100 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53380988 |
| 101 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.53108208 |
| 102 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.53108208 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.53080200 |
| 104 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.52984928 |
| 105 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.52819064 |
| 106 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52362911 |
| 107 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51968502 |
| 108 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.51804768 |
| 109 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50901223 |
| 110 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50653778 |
| 111 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.50171495 |
| 112 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.50071870 |
| 113 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.49640727 |
| 114 | CBP_21632823_ChIP-Seq_H3396_Human | 0.49526048 |
| 115 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49224739 |
| 116 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.47087460 |
| 117 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.46113459 |
| 118 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45850925 |
| 119 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.45211083 |
| 120 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 0.44931236 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42931158 |
| 122 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.42443401 |
| 123 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.41461378 |
| 124 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.41406182 |
| 125 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.41335609 |
| 126 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.41070141 |
| 127 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.41028092 |
| 128 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.39906204 |
| 129 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.39808902 |
| 130 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.39632439 |
| 131 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.39538161 |
| 132 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.39324657 |
| 133 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.37878737 |
| 134 | NCOR_22424771_ChIP-Seq_293T_Human | 0.37836220 |
| 135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.37663817 |
| 136 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37583898 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.37332401 |
| 138 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36857899 |
| 139 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.36701406 |
| 140 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.36507466 |
| 141 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.36416576 |
| 142 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.36056834 |
| 143 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.35817876 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.27480188 |
| 2 | MP0005360_urolithiasis | 7.71538204 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.39062378 |
| 4 | MP0005365_abnormal_bile_salt | 6.16006045 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 5.14028894 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.12972787 |
| 7 | MP0003252_abnormal_bile_duct | 3.85680262 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.53668509 |
| 9 | MP0009840_abnormal_foam_cell | 3.32100904 |
| 10 | MP0003195_calcinosis | 3.04282561 |
| 11 | MP0005332_abnormal_amino_acid | 2.99715058 |
| 12 | MP0005083_abnormal_biliary_tract | 2.93678572 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.54320691 |
| 14 | MP0004019_abnormal_vitamin_homeostasis | 2.44142002 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.30234278 |
| 16 | MP0000609_abnormal_liver_physiology | 2.14714105 |
| 17 | MP0002138_abnormal_hepatobiliary_system | 2.11650750 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.08572877 |
| 19 | MP0005319_abnormal_enzyme/_coenzyme | 1.83994717 |
| 20 | MP0003868_abnormal_feces_composition | 1.81928704 |
| 21 | MP0001764_abnormal_homeostasis | 1.80297301 |
| 22 | MP0005451_abnormal_body_composition | 1.63974007 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.60277104 |
| 24 | MP0009697_abnormal_copulation | 1.57941950 |
| 25 | MP0009643_abnormal_urine_homeostasis | 1.39423973 |
| 26 | MP0003186_abnormal_redox_activity | 1.35494375 |
| 27 | MP0003011_delayed_dark_adaptation | 1.34575393 |
| 28 | MP0003656_abnormal_erythrocyte_physiolo | 1.22966698 |
| 29 | MP0000598_abnormal_liver_morphology | 1.16143186 |
| 30 | MP0005647_abnormal_sex_gland | 1.14119968 |
| 31 | MP0005636_abnormal_mineral_homeostasis | 1.07711933 |
| 32 | MP0009764_decreased_sensitivity_to | 1.05840665 |
| 33 | MP0000604_amyloidosis | 0.98637199 |
| 34 | MP0009763_increased_sensitivity_to | 0.96733077 |
| 35 | MP0002876_abnormal_thyroid_physiology | 0.92858278 |
| 36 | MP0003705_abnormal_hypodermis_morpholog | 0.92392153 |
| 37 | MP0002254_reproductive_system_inflammat | 0.90617892 |
| 38 | MP0009642_abnormal_blood_homeostasis | 0.89122118 |
| 39 | MP0008469_abnormal_protein_level | 0.88960446 |
| 40 | MP0010368_abnormal_lymphatic_system | 0.88382144 |
| 41 | MP0006036_abnormal_mitochondrial_physio | 0.85775596 |
| 42 | MP0005408_hypopigmentation | 0.85278061 |
| 43 | MP0005670_abnormal_white_adipose | 0.85170761 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 0.82899145 |
| 45 | MP0001661_extended_life_span | 0.82306515 |
| 46 | MP0005376_homeostasis/metabolism_phenot | 0.78895924 |
| 47 | MP0001915_intracranial_hemorrhage | 0.77882681 |
| 48 | MP0009765_abnormal_xenobiotic_induced | 0.77110959 |
| 49 | MP0002078_abnormal_glucose_homeostasis | 0.76246765 |
| 50 | MP0003879_abnormal_hair_cell | 0.75193170 |
| 51 | MP0001756_abnormal_urination | 0.74854985 |
| 52 | MP0002971_abnormal_brown_adipose | 0.71993134 |
| 53 | MP0005187_abnormal_penis_morphology | 0.70757929 |
| 54 | MP0005535_abnormal_body_temperature | 0.70413261 |
| 55 | MP0005220_abnormal_exocrine_pancreas | 0.69657785 |
| 56 | MP0003718_maternal_effect | 0.68873039 |
| 57 | MP0005334_abnormal_fat_pad | 0.68092020 |
| 58 | MP0006035_abnormal_mitochondrial_morpho | 0.65264125 |
| 59 | MP0003959_abnormal_lean_body | 0.62355812 |
| 60 | MP0004130_abnormal_muscle_cell | 0.62040663 |
| 61 | MP0003690_abnormal_glial_cell | 0.61083266 |
| 62 | MP0005266_abnormal_metabolism | 0.60314234 |
| 63 | MP0005395_other_phenotype | 0.60291827 |
| 64 | MP0009053_abnormal_anal_canal | 0.58522525 |
| 65 | MP0002136_abnormal_kidney_physiology | 0.58422185 |
| 66 | MP0003329_amyloid_beta_deposits | 0.54870949 |
| 67 | MP0000639_abnormal_adrenal_gland | 0.53980498 |
| 68 | MP0005023_abnormal_wound_healing | 0.53412199 |
| 69 | MP0005448_abnormal_energy_balance | 0.51774225 |
| 70 | MP0005164_abnormal_response_to | 0.51430015 |
| 71 | MP0002282_abnormal_trachea_morphology | 0.51371554 |
| 72 | MP0004272_abnormal_basement_membrane | 0.51018623 |
| 73 | MP0003950_abnormal_plasma_membrane | 0.49928600 |
| 74 | MP0004381_abnormal_hair_follicle | 0.49410670 |
| 75 | MP0010386_abnormal_urinary_bladder | 0.47763168 |
| 76 | MP0005464_abnormal_platelet_physiology | 0.46800718 |
| 77 | MP0002928_abnormal_bile_duct | 0.46420884 |
| 78 | MP0004043_abnormal_pH_regulation | 0.46414345 |
| 79 | MP0002822_catalepsy | 0.45748073 |
| 80 | MP0003638_abnormal_response/metabolism_ | 0.45641099 |
| 81 | MP0004782_abnormal_surfactant_physiolog | 0.43152076 |
| 82 | MP0003953_abnormal_hormone_level | 0.42929252 |
| 83 | MP0008873_increased_physiological_sensi | 0.41107536 |
| 84 | MP0003724_increased_susceptibility_to | 0.41073616 |
| 85 | MP0008874_decreased_physiological_sensi | 0.40139717 |
| 86 | MP0009672_abnormal_birth_weight | 0.38796260 |
| 87 | MP0008872_abnormal_physiological_respon | 0.38418479 |
| 88 | MP0009785_altered_susceptibility_to | 0.36078818 |
| 89 | MP0002168_other_aberrant_phenotype | 0.35272477 |
| 90 | MP0002132_abnormal_respiratory_system | 0.34668425 |
| 91 | MP0000579_abnormal_nail_morphology | 0.34376870 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.34229577 |
| 93 | MP0009115_abnormal_fat_cell | 0.33675498 |
| 94 | MP0005375_adipose_tissue_phenotype | 0.33112858 |
| 95 | MP0005666_abnormal_adipose_tissue | 0.33037501 |
| 96 | MP0005058_abnormal_lysosome_morphology | 0.32843256 |
| 97 | MP0003436_decreased_susceptibility_to | 0.31573250 |
| 98 | MP0009780_abnormal_chondrocyte_physiolo | 0.31037802 |
| 99 | MP0005166_decreased_susceptibility_to | 0.30196557 |
| 100 | MP0002909_abnormal_adrenal_gland | 0.30152313 |
| 101 | MP0002796_impaired_skin_barrier | 0.30116818 |
| 102 | MP0006082_CNS_inflammation | 0.29469306 |
| 103 | MP0001765_abnormal_ion_homeostasis | 0.29400075 |
| 104 | MP0005248_abnormal_Harderian_gland | 0.29244468 |
| 105 | MP0003075_altered_response_to | 0.28587926 |
| 106 | MP0002837_dystrophic_cardiac_calcinosis | 0.28364163 |
| 107 | MP0002249_abnormal_larynx_morphology | 0.27788874 |
| 108 | MP0002970_abnormal_white_adipose | 0.27488388 |
| 109 | MP0005551_abnormal_eye_electrophysiolog | 0.27325430 |
| 110 | MP0001845_abnormal_inflammatory_respons | 0.27116075 |
| 111 | MP0004883_abnormal_blood_vessel | 0.26724128 |
| 112 | MP0000467_abnormal_esophagus_morphology | 0.26463350 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.26420999 |
| 114 | MP0000249_abnormal_blood_vessel | 0.25769661 |
| 115 | MP0002135_abnormal_kidney_morphology | 0.24905402 |
| 116 | MP0001881_abnormal_mammary_gland | 0.24763851 |
| 117 | MP0001243_abnormal_dermal_layer | 0.24422650 |
| 118 | MP0001944_abnormal_pancreas_morphology | 0.24150485 |
| 119 | MP0001851_eye_inflammation | 0.23850260 |
| 120 | MP0000538_abnormal_urinary_bladder | 0.23696783 |
| 121 | MP0002128_abnormal_blood_circulation | 0.23031869 |
| 122 | MP0005197_abnormal_uvea_morphology | 0.23021029 |
| 123 | MP0002332_abnormal_exercise_endurance | 0.21343903 |
| 124 | MP0003646_muscle_fatigue | 0.21099411 |
| 125 | MP0005452_abnormal_adipose_tissue | 0.20022031 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.39341534 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.14681917 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.11519891 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.56931646 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.47038077 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.23358387 |
| 7 | Xanthomatosis (HP:0000991) | 6.16315881 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.46052687 |
| 9 | Complement deficiency (HP:0004431) | 5.11406918 |
| 10 | Hyperglycinemia (HP:0002154) | 4.83930459 |
| 11 | Joint hemorrhage (HP:0005261) | 4.80381573 |
| 12 | Hyperammonemia (HP:0001987) | 4.68497326 |
| 13 | Hypolipoproteinemia (HP:0010981) | 4.67556362 |
| 14 | Hyperglycinuria (HP:0003108) | 4.41792837 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.35978478 |
| 16 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.33829462 |
| 17 | Epidermoid cyst (HP:0200040) | 4.31949279 |
| 18 | Abnormality of glycine metabolism (HP:0010895) | 4.31148907 |
| 19 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.31148907 |
| 20 | Ketosis (HP:0001946) | 4.30546381 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 4.27622118 |
| 22 | Abnormality of methionine metabolism (HP:0010901) | 4.26889805 |
| 23 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.26786122 |
| 24 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.26645095 |
| 25 | Hypoalphalipoproteinemia (HP:0003233) | 4.10221622 |
| 26 | Fat malabsorption (HP:0002630) | 4.03589521 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.99219222 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.77358581 |
| 29 | Nephritis (HP:0000123) | 3.70698005 |
| 30 | Abnormality of complement system (HP:0005339) | 3.68983463 |
| 31 | Conjugated hyperbilirubinemia (HP:0002908) | 3.65870157 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.64495615 |
| 33 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48854786 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.48763286 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.34485898 |
| 36 | Abnormality of serum amino acid levels (HP:0003112) | 3.33247628 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.29483328 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.24448508 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.22336447 |
| 40 | Ketoacidosis (HP:0001993) | 3.07711766 |
| 41 | Steatorrhea (HP:0002570) | 3.04538464 |
| 42 | Gout (HP:0001997) | 2.98933057 |
| 43 | Spontaneous abortion (HP:0005268) | 2.95642573 |
| 44 | Hepatocellular carcinoma (HP:0001402) | 2.94985426 |
| 45 | Abnormality of purine metabolism (HP:0004352) | 2.94615380 |
| 46 | Osteomalacia (HP:0002749) | 2.91491471 |
| 47 | Myocardial infarction (HP:0001658) | 2.89894110 |
| 48 | Metabolic acidosis (HP:0001942) | 2.88990989 |
| 49 | Hypochromic microcytic anemia (HP:0004840) | 2.82255552 |
| 50 | Lethargy (HP:0001254) | 2.80931555 |
| 51 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.79257389 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.79257389 |
| 53 | Vascular calcification (HP:0004934) | 2.71930941 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.64455462 |
| 55 | Skin nodule (HP:0200036) | 2.57520880 |
| 56 | Hyperphosphaturia (HP:0003109) | 2.56990524 |
| 57 | Cerebral edema (HP:0002181) | 2.54545935 |
| 58 | Spastic diplegia (HP:0001264) | 2.47295801 |
| 59 | Irritability (HP:0000737) | 2.46082735 |
| 60 | Acanthocytosis (HP:0001927) | 2.40404540 |
| 61 | Cardiovascular calcification (HP:0011915) | 2.39038282 |
| 62 | Glomerulonephritis (HP:0000099) | 2.37399931 |
| 63 | Hypoglycemic seizures (HP:0002173) | 2.37251736 |
| 64 | Purpura (HP:0000979) | 2.36681615 |
| 65 | Abnormality of vitamin metabolism (HP:0100508) | 2.33274949 |
| 66 | Malnutrition (HP:0004395) | 2.33063681 |
| 67 | Neonatal onset (HP:0003623) | 2.32696030 |
| 68 | Reduced antithrombin III activity (HP:0001976) | 2.29937109 |
| 69 | Mitral stenosis (HP:0001718) | 2.29207486 |
| 70 | Enlarged kidneys (HP:0000105) | 2.25600445 |
| 71 | Abnormal gallbladder morphology (HP:0012437) | 2.25532479 |
| 72 | Generalized aminoaciduria (HP:0002909) | 2.24895980 |
| 73 | Fair hair (HP:0002286) | 2.24639431 |
| 74 | Vomiting (HP:0002013) | 2.21901262 |
| 75 | Pancreatitis (HP:0001733) | 2.20361113 |
| 76 | Cholelithiasis (HP:0001081) | 2.19562659 |
| 77 | Arthropathy (HP:0003040) | 2.19312924 |
| 78 | Brushfield spots (HP:0001088) | 2.18822318 |
| 79 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.18049271 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.17173816 |
| 81 | Proximal tubulopathy (HP:0000114) | 2.15296705 |
| 82 | Alkalosis (HP:0001948) | 2.14739772 |
| 83 | Pulmonary embolism (HP:0002204) | 2.11788919 |
| 84 | Amyloidosis (HP:0011034) | 2.11369001 |
| 85 | Opisthotonus (HP:0002179) | 2.10114142 |
| 86 | Cholecystitis (HP:0001082) | 2.09923196 |
| 87 | Abnormal gallbladder physiology (HP:0012438) | 2.09923196 |
| 88 | Gingival bleeding (HP:0000225) | 2.08367327 |
| 89 | Rickets (HP:0002748) | 2.07952690 |
| 90 | Abnormal urine phosphate concentration (HP:0012599) | 2.07349915 |
| 91 | Hyperuricemia (HP:0002149) | 2.06871772 |
| 92 | Increased purine levels (HP:0004368) | 2.06871772 |
| 93 | Menorrhagia (HP:0000132) | 2.06485771 |
| 94 | Esophageal varix (HP:0002040) | 2.05097445 |
| 95 | Thrombophlebitis (HP:0004418) | 2.03632651 |
| 96 | Late onset (HP:0003584) | 2.02394737 |
| 97 | Renal cortical cysts (HP:0000803) | 1.98072544 |
| 98 | Hydroxyprolinuria (HP:0003080) | 1.95324743 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 1.95324743 |
| 100 | Hypophosphatemic rickets (HP:0004912) | 1.94275600 |
| 101 | Poikilocytosis (HP:0004447) | 1.91438454 |
| 102 | Abnormality of the gallbladder (HP:0005264) | 1.91065824 |
| 103 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.90777403 |
| 104 | Abnormality of urine glucose concentration (HP:0011016) | 1.89745852 |
| 105 | Glycosuria (HP:0003076) | 1.89745852 |
| 106 | Facial shape deformation (HP:0011334) | 1.89665724 |
| 107 | Potter facies (HP:0002009) | 1.89665724 |
| 108 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.88983486 |
| 109 | Bile duct proliferation (HP:0001408) | 1.88943997 |
| 110 | Abnormal biliary tract physiology (HP:0012439) | 1.88943997 |
| 111 | Elevated alkaline phosphatase (HP:0003155) | 1.86302294 |
| 112 | Hemorrhage of the eye (HP:0011885) | 1.85476401 |
| 113 | Increased circulating renin level (HP:0000848) | 1.83291409 |
| 114 | Abnormal cartilage morphology (HP:0002763) | 1.83183995 |
| 115 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.82977668 |
| 116 | Joint swelling (HP:0001386) | 1.82765926 |
| 117 | Elevated hepatic transaminases (HP:0002910) | 1.81884515 |
| 118 | Cerebral palsy (HP:0100021) | 1.80098748 |
| 119 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.76043149 |
| 120 | Bifid scrotum (HP:0000048) | 1.74331115 |
| 121 | Abnormality of the Achilles tendon (HP:0005109) | 1.72036033 |
| 122 | Increased mean platelet volume (HP:0011877) | 1.67862805 |
| 123 | Impaired platelet aggregation (HP:0003540) | 1.67823606 |
| 124 | Abnormal platelet function (HP:0011869) | 1.67823606 |
| 125 | Abnormality of iron homeostasis (HP:0011031) | 1.66956780 |
| 126 | Gangrene (HP:0100758) | 1.64141231 |
| 127 | Hypophosphatemia (HP:0002148) | 1.61596962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.71080315 |
| 2 | FGFR4 | 4.80315529 |
| 3 | SIK1 | 4.20577769 |
| 4 | ERN1 | 3.92124098 |
| 5 | INSRR | 3.10537526 |
| 6 | TAOK3 | 2.95479599 |
| 7 | ERBB4 | 2.82344237 |
| 8 | MYLK | 2.49471707 |
| 9 | MAP2K4 | 2.21315215 |
| 10 | PIK3CA | 2.17702282 |
| 11 | MST1R | 2.14679132 |
| 12 | PIK3CG | 2.04053877 |
| 13 | TYK2 | 1.91340784 |
| 14 | MAPK11 | 1.84230454 |
| 15 | ABL2 | 1.62353248 |
| 16 | FLT3 | 1.59893337 |
| 17 | LATS1 | 1.55529791 |
| 18 | MAPKAPK3 | 1.54805124 |
| 19 | PINK1 | 1.48732318 |
| 20 | STK38L | 1.48727173 |
| 21 | DAPK2 | 1.46389972 |
| 22 | PKN2 | 1.41434560 |
| 23 | MAP3K12 | 1.38410700 |
| 24 | NTRK3 | 1.33666043 |
| 25 | NEK9 | 1.32185045 |
| 26 | KDR | 1.28042000 |
| 27 | AKT3 | 1.25070877 |
| 28 | IRAK3 | 1.24174069 |
| 29 | MAP4K2 | 1.19363367 |
| 30 | TRPM7 | 1.19170286 |
| 31 | FRK | 1.18204872 |
| 32 | PDK3 | 1.16942692 |
| 33 | PDK4 | 1.16942692 |
| 34 | FGFR2 | 1.15908131 |
| 35 | MAP3K4 | 1.15886334 |
| 36 | PTK6 | 1.13816042 |
| 37 | JAK2 | 1.13420942 |
| 38 | PRKAA2 | 1.11722945 |
| 39 | GRK1 | 1.06510649 |
| 40 | MAPK15 | 1.05568702 |
| 41 | FER | 1.04365192 |
| 42 | TRIB3 | 1.02059968 |
| 43 | GRK6 | 1.01379966 |
| 44 | EIF2AK1 | 1.01050279 |
| 45 | MAP3K7 | 1.00656923 |
| 46 | MAP2K3 | 0.99221839 |
| 47 | CAMKK2 | 0.98273625 |
| 48 | ADRBK2 | 0.97815020 |
| 49 | MAP3K14 | 0.97274669 |
| 50 | MAPK4 | 0.94574685 |
| 51 | JAK1 | 0.94164905 |
| 52 | GRK7 | 0.92170093 |
| 53 | PRKCZ | 0.91712156 |
| 54 | STK39 | 0.89665046 |
| 55 | SCYL2 | 0.89241587 |
| 56 | PRKG1 | 0.87709954 |
| 57 | ERBB2 | 0.87624454 |
| 58 | TIE1 | 0.87060921 |
| 59 | MAP3K3 | 0.84343323 |
| 60 | WNK3 | 0.82662665 |
| 61 | NLK | 0.82600047 |
| 62 | PRKACA | 0.81504020 |
| 63 | TBK1 | 0.80469437 |
| 64 | MAPK12 | 0.79253071 |
| 65 | PRKCE | 0.79051768 |
| 66 | MAP3K11 | 0.78041938 |
| 67 | PRKACG | 0.76611124 |
| 68 | PRKAA1 | 0.76100870 |
| 69 | SGK3 | 0.75840894 |
| 70 | OBSCN | 0.75130602 |
| 71 | SGK2 | 0.75023520 |
| 72 | STK16 | 0.73529899 |
| 73 | STK38 | 0.73350297 |
| 74 | MET | 0.72530199 |
| 75 | BCR | 0.72030271 |
| 76 | CAMK2G | 0.71599007 |
| 77 | KIT | 0.71555463 |
| 78 | GSK3A | 0.71373121 |
| 79 | MAPK7 | 0.71196750 |
| 80 | MAP2K6 | 0.70103056 |
| 81 | BMPR1B | 0.67114453 |
| 82 | TAOK2 | 0.65761689 |
| 83 | ADRBK1 | 0.65421558 |
| 84 | SGK223 | 0.63819624 |
| 85 | SGK494 | 0.63819624 |
| 86 | DYRK1B | 0.63643187 |
| 87 | EPHA3 | 0.63635039 |
| 88 | CDK6 | 0.63471344 |
| 89 | PDK2 | 0.63081396 |
| 90 | EPHB1 | 0.63015102 |
| 91 | MUSK | 0.61587384 |
| 92 | ACVR1B | 0.56458164 |
| 93 | CSNK1D | 0.56195486 |
| 94 | MAP2K7 | 0.56136312 |
| 95 | IKBKE | 0.55880139 |
| 96 | CSK | 0.54873868 |
| 97 | CSNK1G1 | 0.54527209 |
| 98 | DDR2 | 0.54478948 |
| 99 | PRKCG | 0.52484607 |
| 100 | MAP3K6 | 0.50908101 |
| 101 | MAP3K2 | 0.50299608 |
| 102 | MAP3K10 | 0.49611605 |
| 103 | PDPK1 | 0.48516095 |
| 104 | CDK4 | 0.46981267 |
| 105 | RPS6KA3 | 0.46301571 |
| 106 | TGFBR2 | 0.45213199 |
| 107 | PRKCQ | 0.45054054 |
| 108 | WNK4 | 0.44646056 |
| 109 | BRSK2 | 0.44526511 |
| 110 | MAP3K5 | 0.44349123 |
| 111 | PRKACB | 0.44340048 |
| 112 | PTK2 | 0.43918190 |
| 113 | EPHA4 | 0.43382728 |
| 114 | SRC | 0.42850874 |
| 115 | PRKCB | 0.41762278 |
| 116 | OXSR1 | 0.41685621 |
| 117 | GRK5 | 0.41657393 |
| 118 | IGF1R | 0.40941734 |
| 119 | SGK1 | 0.38029249 |
| 120 | CSF1R | 0.37451527 |
| 121 | PKN1 | 0.36864541 |
| 122 | CAMK1D | 0.36269478 |
| 123 | PAK2 | 0.36214403 |
| 124 | FGFR3 | 0.35313420 |
| 125 | PBK | 0.34270599 |
| 126 | MTOR | 0.34090776 |
| 127 | RET | 0.33808545 |
| 128 | STK3 | 0.33474486 |
| 129 | IRAK2 | 0.30943059 |
| 130 | IRAK1 | 0.28964935 |
| 131 | EGFR | 0.28686735 |
| 132 | PDK1 | 0.27965942 |
| 133 | PRKCA | 0.27469286 |
| 134 | MAP2K1 | 0.25010924 |
| 135 | CSNK1G3 | 0.23981162 |
| 136 | ABL1 | 0.23117359 |
| 137 | EPHA2 | 0.22331554 |
| 138 | CAMK4 | 0.21086592 |
| 139 | RIPK1 | 0.20778782 |
| 140 | MAP3K13 | 0.20527313 |
| 141 | CSNK1G2 | 0.20465767 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.40456387 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.37330628 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.33141242 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.30296903 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.99918554 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.73431285 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.69208989 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.66011138 |
| 9 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.65298210 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.63611320 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.47411526 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.44346918 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.30308600 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.25375841 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.13448193 |
| 16 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.10499632 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.98310006 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.91719489 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90500991 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.90030081 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.89372540 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.82526646 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.80522264 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.78463925 |
| 25 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.77441306 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.76926265 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72182673 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.70868617 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.70114703 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.68078146 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.62576326 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60813807 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57442993 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.56824453 |
| 35 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.51791899 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.43819454 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.42308477 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.38936448 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.36353936 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.33805714 |
| 41 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30171052 |
| 42 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.26287446 |
| 43 | * Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.25878501 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24976631 |
| 45 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.24384397 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.23191209 |
| 47 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18070190 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.16847791 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.14676967 |
| 50 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13196756 |
| 51 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.10434431 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02513421 |
| 53 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.00916888 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.00654345 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.97065793 |
| 56 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95415744 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93155842 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.87578750 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.81156387 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.79459598 |
| 61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73931802 |
| 62 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.71861638 |
| 63 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.71591895 |
| 64 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67456655 |
| 65 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.50860873 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50094537 |
| 67 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.45800101 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33574015 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.30957251 |
| 70 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.30779966 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.28690339 |
| 72 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.26172483 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.25746954 |
| 74 | Galactose metabolism_Homo sapiens_hsa00052 | 0.24069713 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.23673858 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22112813 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.16986642 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16041639 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.04833701 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.04484784 |
| 81 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.00670606 |
| 82 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2445795 |
| 83 | Mineral absorption_Homo sapiens_hsa04978 | -0.2432892 |
| 84 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2427299 |
| 85 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2348128 |
| 86 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2336271 |
| 87 | Pyrimidine metabolism_Homo sapiens_hsa00240 | -0.2308557 |
| 88 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2202279 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2117505 |
| 90 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2066814 |
| 91 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2053980 |
| 92 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.1987283 |
| 93 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | -0.1913476 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1885312 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | -0.1872380 |
| 96 | Amoebiasis_Homo sapiens_hsa05146 | -0.1599035 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1575284 |
| 98 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1325289 |
| 99 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1309998 |
| 100 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1268329 |
| 101 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1130748 |
| 102 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1071754 |
| 103 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0835739 |
| 104 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0723433 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0600666 |
| 106 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0433834 |
| 107 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0073194 |
| 108 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0066600 |
| 109 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0026429 |

